The Diagnosis and Treatment of COPD and Its Comorbidities

被引:136
作者
Kahnert, Kathrin [1 ,4 ]
Joerres, Rudolf A. [2 ]
Behr, Juergen [1 ]
Welte, Tobias [3 ]
机构
[1] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 5, Comprehens Pneumol Ctr,German Ctr Lung Res DZL, Munich, Germany
[2] Ludwig Maximilians Univ LMU, Inst Occupat Social & Environm Med, Comprehens Pneumol Ctr Munich, Munich, Germany
[3] Hannover Med Sch, Dept Resp Med, German Ctr Lung Res DZL, Hannover, Germany
[4] Klinikum Univ Munchen LMU, Med Klin & Poliklin 5, Ziemssenstr 1, D-80336 Munich, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2023年 / 120卷 / 25期
关键词
OBSTRUCTIVE PULMONARY-DISEASE; ALL-CAUSE MORTALITY; DOUBLE-BLIND; RISK; PREVALENCE; FAILURE; COHORT;
D O I
10.3238/arztebl.m2023.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic obstructive pulmonary disease (COPD) is the third most common cause of death around the world. The affected patients suffer not only from impaired lung function, but also from a wide variety of comorbidities. Their cardiac comorbidities, in particular, lead to increased mortality.Methods: This review is based on pertinent publications retrieved by a selective search in PubMed, including guidelines from Germany and abroad.Results: The usual diagnostic criteria for COPD are a post-bronchodilator FEV1/FVC quotient below the fixed threshold of 0.7, or, preferably, below the lower limit of normal (LLN) according to the GLI reference values for the avoidance of over-and under diagnosis. The overall prognosis is markedly affected by comorbidities of the lung itself and those that involve other organs; in particular, many persons with COPD die of heart disease. The potential presence of heart disease must be borne in mind in the evaluation of patients with COPD, as lung disease can impair the detection of heart disease. Conclusion: As patients with COPD are often multimorbid, the early diagnosis and adequate treatment not only of their lung disease, but also of their extrapulmonary comorbidities are very important. Well-established diagnostic instruments and well-tested treatments are available and are described in detail in the guidelines concerning the comorbidities. Preliminary observations suggest that more attention should be paid to the potential positive effects of treating comorbidities on the lung disease itself, and vice versa.
引用
收藏
页数:14
相关论文
共 38 条
[1]   Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].
Aberle, Denise R. ;
Adams, Amanda M. ;
Berg, Christine D. ;
Black, William C. ;
Clapp, Jonathan D. ;
Fagerstrom, Richard M. ;
Gareen, Ilana F. ;
Gatsonis, Constantine ;
Marcus, Pamela M. ;
Sicks, JoRean D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409
[2]   Comorbidities and Short-term Prognosis in Patients Hospitalized for Acute Exacerbation of COPD The EPOC en Servicios de Medicina Interna (ESMI) Study [J].
Almagro, Pedro ;
Javier Cabrera, Francisco ;
Diez, Jesus ;
Boixeda, Ramon ;
Alonso Ortiz, M. Belen ;
Murio, Cristina ;
Soriano, Joan B. .
CHEST, 2012, 142 (05) :1126-1133
[3]   Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort [J].
Alter, Peter ;
Mayerhofer, Barbara A. ;
Kahnert, Kathrin ;
Watz, Henrik ;
Waschki, Benjamin ;
Andreas, Stefan ;
Biertz, Frank ;
Bals, Robert ;
Vogelmeier, Claus F. ;
Joerres, Rudolf A. .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 :2163-2172
[4]   Left ventricular volume and wall stress are linked to lung function impairment in COPD [J].
Alter, Peter ;
Joerres, Rudolf A. ;
Watz, Henrik ;
Welte, Tobias ;
Glaeser, Sven ;
Schulz, Holger ;
Bals, Robert ;
Karch, Annika ;
Wouters, Emiel F. M. ;
Vestbo, Jorgen ;
Young, David ;
Vogelmeier, Claus F. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 261 :172-178
[5]  
[Anonymous], GLOBAL STRATEGY DIAG
[6]   Bidirectional Associations Between Clinically Relevant Depression or Anxiety and COPD A Systematic Review and Meta-analysis [J].
Atlantis, Evan ;
Fahey, Paul ;
Cochrane, Belinda ;
Smith, Sheree .
CHEST, 2013, 144 (03) :766-777
[7]   Systemic manifestations and comorbidities of COPD [J].
Barnes, P. J. ;
Celli, B. R. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) :1165-1185
[8]   International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study [J].
Buist, A. Sonia ;
McBurnie, Mary Ann ;
Vollmer, William M. ;
Gillespie, Suzanne ;
Burney, Peter ;
Mannino, David M. ;
Menezes, Ana M. B. ;
Sullivan, Sean D. ;
Lee, Todd A. ;
Weiss, Kevin B. ;
Jensen, Robert L. ;
Marks, Guy B. ;
Gulsvik, Amund ;
Nizankowska-Mogilnicka, Ewa .
LANCET, 2007, 370 (9589) :741-750
[9]   Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management [J].
Campo, Gianluca ;
Pavasini, Rita ;
Malagu, Michele ;
Mascetti, Susanna ;
Biscaglia, Simone ;
Ceconi, Claudio ;
Papi, Alberto ;
Contoli, Marco .
CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (02) :147-157
[10]   Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative [J].
Coiro, Stefano ;
Girerd, Nicolas ;
Rossignol, Patrick ;
Ferreira, Joao Pedro ;
Maggioni, Aldo ;
Pitt, Bertram ;
Tritto, Isabella ;
Ambrosio, Giuseppe ;
Dickstein, Kenneth ;
Zannad, Faiez .
EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (02) :271-279